Seeger, H <br/><br/>
Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function.  [electronic resource] 

 -  Journal of the renin-angiotensin-aldosterone system : JRAAS  Jun 2001 
 - 141-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1470-3203 
<br/><br/><label>Standard No.: </label>10.3317/jraas.2001.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--pharmacology<br/>Antihypertensive Agents--pharmacology<br/>Benzimidazoles--pharmacology<br/>Biphenyl Compounds<br/>Cells, Cultured<br/>Collagenases--metabolism<br/>Coronary Vessels--cytology<br/>Endothelins--metabolism<br/>Endothelium, Vascular--cytology<br/>Enzyme Precursors--metabolism<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 1<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>Tetrazoles--pharmacology<br/>Valine--analogs & derivatives<br/>Valsartan<br/>Vasoconstrictor Agents--pharmacology